Lasers are ubiquitous in science and technology, with applications ranging from optical communications and quantum technologies to metrology and sensing and to life sciences and medical diagnostics. However, most commercially used lasers are still based on legacy optical schemes. These devices are either bulky and expensive limiting product development, or lack the ability to quickly sweep or precisely control the laser wavelength, which is key to many applications. At the same time, the advent of advanced photonic integration platforms such as silicon photonics has opened new perspectives, realized only for exascale data centers in telecommunication wavelengths around 1310 and 1550 nm. AgiLight aims at establishing a new class of integrated lasers that can address the entire wavelength range from the blue (400 nm) to the infrared (2.7 µm). These devices rely on a hybrid integration platform that combines ultra-low-loss silicon nitride photonic circuits with advanced tuning actuators and with III-V gain elements, exploiting highly scalable assembly concepts based on 3D printing. The devices will offer high output powers (> 100 mW), down to Hz-level laser linewidths, and unprecedented frequency agility with nanosecond response times and wideband tunability. Comprising leading European research groups and high-tech start-ups as well as a major industrial player, AgiLight will translate ground-breaking research to rapid technology uptake and tailor laser systems for atomic and molecular physics and optics, distance ranging and sensing using the expertise of end-users. The project covers the theoretical and nanofabrication foundations of the envisaged light sources as well as their implementation and functional demonstration in highly relevant research applications throughout the visible and near-infrared spectrum. AgiLight will lay the foundation for an all-European value chain of a novel class of light sources, covering the III-V and low-loss PICs.

Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure the wellbeing of an increasingly aged population. EuroNanoMed III (ENM III) builds on the foundations of ENM I & II, which launched 7 successful joint calls for proposals since 2009, funded 51 transnational research projects involving 269 partners from 25 countries/regions, and allocated € 45,5 million to research projects from ENM funding agencies. ENM III consortium, reinforced with 12 new partners from Europe, Canada and Taiwan, is committed to fostering the competiveness of European nanomedicine actors taking into account recent changes in the landscape and new stakeholders and challenges, as identified in the SRIA in nanomedicine. The first joint call for proposals will be co-funded by ENM III partners and the EC. After the co-funded call, three additional joint transnational calls will be organized and strategic activities will be accomplished in collaboration with key initiatives in the field. ENM III actions focus on translatability of project results to clinical and industry needs.

The overall goal of the proposed Cofund is to strengthen the European Research Area (ERA) in maritime and marine technologies and Blue Growth. The realisation of a European research and innovation agenda needs a broad and systematic cooperation in all areas of waterborne transport, offshore activity, marine resources, maritime security, biotechnologies, desalination, offshore oil & gas, fisheries, aquaculture etc. covering all relevant maritime and marine sectors and regions for a sustainable development of the maritime sector. Research and innovation activities in these fields cannot be tackled either at national levels alone, or solely by a single sector. Coordinated actions are required for the maritime industry to strengthen Europe’s position in this important and complex economic field in a global market. The proposing consortium will organise and co-fund, together with the EU, a joint call for trans-national research projects on different thematic areas of Blue Growth. Furthermore, additional joint activities that go beyond this co-funded call are planned, in order to contribute to the national priorities as well as to the Strategic Research Agenda of JPI Oceans and WATERBORNE. With the cooperation of ERA-NET MARTEC and JPI Oceans, a broader variety of topics with a larger amount of funding will be available for the trans-national projects. Moreover, the focus of development in MarTERA is given to technologies (instead of sectors) due to their potentially large impact to a wide range of application fields. The proposal responds to the topic ERA-NET Cofund on marine technologies of the work programme 2016-2017 of the societal challenge 2 (Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bio-economy) under Horizon 2020. Thereby it also contributes to the overall EU objective of building the ERA through enhanced cooperation and coordination of national research programmes.